giredestrant
Description: Giredestrant is an oral selective estrogen receptor degrader studied as an endocrine therapy for estrogen receptor-positive breast cancer.
Primary topic: Advanced Breast Cancer Therapies (62%)
Wikidata ID: wiki/Q131198690
OpenAlex ID: keywords/giredestrant
